Piscataway, NJ, September 3, 2025 – Camber Pharmaceuticals is excited to welcome Spironolactone Oral Suspension [spir-ON-oh-LAK-tone] to its expanding portfolio.
Spironolactone Oral Suspension is an antagonist of aldosterone indicated for:
• Treating NYHA Class III–IV heart failure with reduced ejection fraction to improve survival, manage edema, and reduce hospitalizations
• Use as add-on therapy for hypertension to lower blood pressure and reduce the risk of cardiovascular events (strokes, myocardial infarctions)
• Managing edema in adult cirrhotic patients unresponsive to fluid and sodium restriction
For complete indications, please visit Spironolactone Oral Suspension
Spironolactone Oral Suspension is available in 25 mg/5 mL strength and comes in 118 mL and 473 mL bottle sizes.
To learn more about this product, please visit Spironolactone Oral Suspension
